U.S. Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows

Sotera Health

Market Cap: US$3.5b

Provides sterilization, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally.

Vertex Pharmaceuticals

Market Cap: US$114.5b

A biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF).

BioLife Solutions

Market Cap: US$1.1b

Develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally.

Repligen

Market Cap: US$6.9b

A life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally.

Eli Lilly

Market Cap: US$651.1b

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals in the United States, Europe, China, Japan, and internationally.

Niagen Bioscience

Market Cap: US$836.7m

Operates as a bioscience company engages in developing healthy aging products.

Mesa Laboratories

Market Cap: US$615.1m

Develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally.

Bruker

Market Cap: US$5.6b

Develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally.

Natera

Market Cap: US$21.5b

A diagnostics company, provides molecular testing services worldwide.